- Published on
Ophthalmology – Down Syndrome (Trisomy 21)
Down syndrome, also known as Trisomy 21, is a chromosomal disorder caused by the presence of an extra copy of chromosome 21. It was first described by John Langdon Down in 1866. The condition affects individuals worldwide across all ethnic and socioeconomic groups and is one of the most common genetic causes of intellectual disability.
The incidence is approximately 1 in 733 live births in the United States, with risk strongly associated with advanced maternal age. For example, the risk increases significantly from about 1 in 1,562 in women aged 20–24 to about 1 in 19 in women over 45. Increased paternal age has also been identified as a contributing risk factor. Most cases result from meiotic nondisjunction, leading to a full extra chromosome, although partial or mosaic forms may also occur.
Clinically, Down syndrome presents with a characteristic set of physical features. These include a round face, small chin (microgenia), macroglossia (large tongue), and short neck. Ocular findings are particularly relevant in ophthalmology and include epicanthal folds, upward slanting palpebral fissures, and Brushfield spots—small whitish or grayish speckles seen at the periphery of the iris. Patients often also have strabismus, cataracts, and other visual abnormalities. General features include hypotonia, short stature, single palmar crease, and varying degrees of intellectual disability and speech delay.
Down syndrome is associated with multiple systemic conditions. These include thyroid disorders, gastrointestinal anomalies, hematologic malignancies, and an increased risk of early-onset Alzheimer’s disease, often developing before age 50. Fertility is typically reduced, especially in males.
Diagnosis can be made prenatally through screening and diagnostic techniques such as amniocentesis, chorionic villus sampling, or umbilical cord blood sampling. Postnatally, diagnosis is confirmed by karyotype analysis. Ophthalmic evaluation may include imaging such as optical coherence tomography (OCT), which can demonstrate macular hypoplasia, and visual electrophysiologic testing.
There is no cure for Down syndrome, so management focuses on supportive care and treatment of associated conditions. Early intervention programs, including speech therapy, occupational therapy, and educational support, significantly improve developmental outcomes. Ophthalmic issues such as strabismus or cataracts should be managed appropriately to optimize visual function.
Follow-up care is lifelong and multidisciplinary. With advances in medical care and supportive services, life expectancy has improved significantly, increasing from approximately 25 years in 1980 to nearly 50 years or more today. Many individuals now live into adulthood with improved quality of life, although neurodegenerative complications remain a concern later in life.
Down syndrome, also known as Trisomy 21, is a chromosomal disorder caused by the presence of an extra copy of chromosome 21. It was first described by John Langdon Down in 1866. The condition affects individuals worldwide across all ethnic and socioeconomic groups and is one of the most common genetic causes of intellectual disability.
The incidence is approximately 1 in 733 live births in the United States, with risk strongly associated with advanced maternal age. For example, the risk increases significantly from about 1 in 1,562 in women aged 20–24 to about 1 in 19 in women over 45. Increased paternal age has also been identified as a contributing risk factor. Most cases result from meiotic nondisjunction, leading to a full extra chromosome, although partial or mosaic forms may also occur.
Clinically, Down syndrome presents with a characteristic set of physical features. These include a round face, small chin (microgenia), macroglossia (large tongue), and short neck. Ocular findings are particularly relevant in ophthalmology and include epicanthal folds, upward slanting palpebral fissures, and Brushfield spots—small whitish or grayish speckles seen at the periphery of the iris. Patients often also have strabismus, cataracts, and other visual abnormalities. General features include hypotonia, short stature, single palmar crease, and varying degrees of intellectual disability and speech delay.
Down syndrome is associated with multiple systemic conditions. These include thyroid disorders, gastrointestinal anomalies, hematologic malignancies, and an increased risk of early-onset Alzheimer’s disease, often developing before age 50. Fertility is typically reduced, especially in males.
Diagnosis can be made prenatally through screening and diagnostic techniques such as amniocentesis, chorionic villus sampling, or umbilical cord blood sampling. Postnatally, diagnosis is confirmed by karyotype analysis. Ophthalmic evaluation may include imaging such as optical coherence tomography (OCT), which can demonstrate macular hypoplasia, and visual electrophysiologic testing.
There is no cure for Down syndrome, so management focuses on supportive care and treatment of associated conditions. Early intervention programs, including speech therapy, occupational therapy, and educational support, significantly improve developmental outcomes. Ophthalmic issues such as strabismus or cataracts should be managed appropriately to optimize visual function.
Follow-up care is lifelong and multidisciplinary. With advances in medical care and supportive services, life expectancy has improved significantly, increasing from approximately 25 years in 1980 to nearly 50 years or more today. Many individuals now live into adulthood with improved quality of life, although neurodegenerative complications remain a concern later in life.
- Published on
Ophthalmology – Dry Eye Syndrome (Keratoconjunctivitis Sicca)
Dry eye syndrome is a multifactorial disease of the ocular surface characterized by an unstable or insufficient tear film, leading to discomfort, visual disturbance, and potential damage to the cornea and conjunctiva. It is broadly classified into three main types: aqueous tear-deficient, evaporative, and exposure-related dry eye. The condition may occur as an isolated ocular disorder or as part of systemic diseases such as autoimmune conditions.
This is a very common condition, particularly in older adults and females. Prevalence increases with age, affecting up to 19% of individuals over 80 years. Risk factors include aging, female sex, ocular surgeries (such as LASIK or cataract surgery), diabetes, and contact lens use. Environmental factors like low humidity and prolonged screen use also contribute significantly.
The pathophysiology involves tear film instability and ocular surface desiccation, which leads to inflammation, loss of goblet cells, and epithelial damage. Over time, this can result in keratinization and chronic surface changes. In aqueous deficiency, there is reduced tear production, whereas evaporative dry eye is usually due to meibomian gland dysfunction, causing rapid tear evaporation. Exposure-related dry eye results from incomplete eyelid closure or reduced blinking.
Patients commonly report burning, itching, gritty sensation, foreign body sensation, and intermittent blurred vision, especially with prolonged visual tasks like reading or computer use. Symptoms often worsen in dry, windy, or air-conditioned environments and improve in humid conditions. Some patients paradoxically experience excess tearing, which is a reflex response to irritation.
On examination, findings may include conjunctival redness, reduced tear meniscus, and superficial punctate keratitis in exposed areas of the cornea. In evaporative dry eye, signs of meibomian gland dysfunction such as thickened secretions, lid margin inflammation, and foamy tear film may be present. Severe cases may show filamentary keratitis or epithelial defects.
Diagnosis is supported by clinical tests. The Schirmer test measures tear production, with low values indicating aqueous deficiency. The tear breakup time (TBUT) assesses tear film stability, with values less than 10 seconds suggesting evaporative dry eye. Rose Bengal staining highlights damaged or devitalized epithelial cells and helps assess severity.
Management is stepwise and depends on severity and type. First-line treatment includes artificial tears, gels, and ointments to supplement and preserve moisture. Environmental modifications such as using humidifiers and avoiding irritants are also important. For evaporative causes, warm compresses and lid hygiene are essential, and oral doxycycline or omega-3 supplements may be beneficial.
Second-line therapies include topical cyclosporine, autologous serum eye drops, and systemic secretagogues such as pilocarpine or cevimeline in selected cases. In more severe disease, procedures such as punctal plugs or punctal occlusion help retain tears. For exposure-related cases, interventions like lid taping, moisture chambers, or surgical options (e.g., tarsorrhaphy) may be required.
Patients should be advised to stay hydrated, blink frequently during screen use, and avoid dry environments. Referral to a specialist is indicated if systemic conditions like Sjögren’s syndrome are suspected.
The prognosis is generally excellent, with most patients achieving good symptom control with appropriate therapy. However, untreated or severe cases can lead to complications such as filamentary keratitis, corneal ulceration, or rarely corneal perforation, highlighting the importance of early recognition and management.
Dry eye syndrome is a multifactorial disease of the ocular surface characterized by an unstable or insufficient tear film, leading to discomfort, visual disturbance, and potential damage to the cornea and conjunctiva. It is broadly classified into three main types: aqueous tear-deficient, evaporative, and exposure-related dry eye. The condition may occur as an isolated ocular disorder or as part of systemic diseases such as autoimmune conditions.
This is a very common condition, particularly in older adults and females. Prevalence increases with age, affecting up to 19% of individuals over 80 years. Risk factors include aging, female sex, ocular surgeries (such as LASIK or cataract surgery), diabetes, and contact lens use. Environmental factors like low humidity and prolonged screen use also contribute significantly.
The pathophysiology involves tear film instability and ocular surface desiccation, which leads to inflammation, loss of goblet cells, and epithelial damage. Over time, this can result in keratinization and chronic surface changes. In aqueous deficiency, there is reduced tear production, whereas evaporative dry eye is usually due to meibomian gland dysfunction, causing rapid tear evaporation. Exposure-related dry eye results from incomplete eyelid closure or reduced blinking.
Patients commonly report burning, itching, gritty sensation, foreign body sensation, and intermittent blurred vision, especially with prolonged visual tasks like reading or computer use. Symptoms often worsen in dry, windy, or air-conditioned environments and improve in humid conditions. Some patients paradoxically experience excess tearing, which is a reflex response to irritation.
On examination, findings may include conjunctival redness, reduced tear meniscus, and superficial punctate keratitis in exposed areas of the cornea. In evaporative dry eye, signs of meibomian gland dysfunction such as thickened secretions, lid margin inflammation, and foamy tear film may be present. Severe cases may show filamentary keratitis or epithelial defects.
Diagnosis is supported by clinical tests. The Schirmer test measures tear production, with low values indicating aqueous deficiency. The tear breakup time (TBUT) assesses tear film stability, with values less than 10 seconds suggesting evaporative dry eye. Rose Bengal staining highlights damaged or devitalized epithelial cells and helps assess severity.
Management is stepwise and depends on severity and type. First-line treatment includes artificial tears, gels, and ointments to supplement and preserve moisture. Environmental modifications such as using humidifiers and avoiding irritants are also important. For evaporative causes, warm compresses and lid hygiene are essential, and oral doxycycline or omega-3 supplements may be beneficial.
Second-line therapies include topical cyclosporine, autologous serum eye drops, and systemic secretagogues such as pilocarpine or cevimeline in selected cases. In more severe disease, procedures such as punctal plugs or punctal occlusion help retain tears. For exposure-related cases, interventions like lid taping, moisture chambers, or surgical options (e.g., tarsorrhaphy) may be required.
Patients should be advised to stay hydrated, blink frequently during screen use, and avoid dry environments. Referral to a specialist is indicated if systemic conditions like Sjögren’s syndrome are suspected.
The prognosis is generally excellent, with most patients achieving good symptom control with appropriate therapy. However, untreated or severe cases can lead to complications such as filamentary keratitis, corneal ulceration, or rarely corneal perforation, highlighting the importance of early recognition and management.
- Published on
Ophthalmology – Esotropia (Comitant)
Comitant esotropia is a form of strabismus in which one eye deviates inward toward the nose, with the key feature that the angle of deviation remains the same in all directions of gaze. It may be intermittent or constant and includes several subtypes such as accommodative, nonaccommodative, sensory, congenital/infantile, consecutive (after exotropia surgery), and cyclic esotropia. Rarely, it may be associated with systemic conditions such as ocular myasthenia gravis or thyroid eye disease.
This condition is relatively common in childhood, with an incidence of about 111 per 100,000 children under 19 years and a prevalence of approximately 2% in children under 6 years. Risk factors include hyperopia (farsightedness), poor vision in one or both eyes (sensory esotropia), prematurity, cerebral palsy, seizure disorders, and developmental delay. There is also a multifactorial genetic component, particularly in accommodative esotropia, where a strong family history is often present.
The pathophysiology depends on the subtype. In accommodative esotropia, excessive focusing effort to overcome hyperopia leads to increased convergence, resulting in inward deviation. In other forms, no clear abnormality in muscles or nerves is identified. Acute onset esotropia may raise concern for intracranial pathology such as tumors, Chiari malformation, or hydrocephalus.
Etiologically, accommodative esotropia is strongly linked to uncorrected hyperopia. Sensory esotropia arises when poor vision disrupts binocular alignment, often due to conditions like cataract or retinal disease. Acute comitant esotropia may indicate neurologic disease, and should prompt further evaluation.
Clinically, esotropia is often first noticed by parents in children, sometimes beginning intermittently and progressing to constant deviation. Symptoms may include crossed eyes, diplopia (in acute cases), or decreased vision. A history of neurologic issues, developmental delay, or prematurity may also be present.
On examination, a complete ophthalmic evaluation is essential. This includes cycloplegic refraction (often requiring atropine), assessment of ocular alignment in all gaze positions, and testing of stereoacuity. The AC/A ratio (accommodative convergence to accommodation) is particularly important in evaluating accommodative esotropia. Visual acuity testing is crucial to identify amblyopia, a common associated condition.
Diagnostic testing is usually not required unless atypical features are present. In suspected cases of myasthenia gravis, antibody testing or a Tensilon test may be performed. If thyroid eye disease is suspected, thyroid function tests are indicated. Neuroimaging (MRI of brain and orbits) is reserved for cases with acute onset or associated neurologic signs.
The differential diagnosis includes pseudoesotropia (common in infants with prominent epicanthal folds), incomitant esotropia, and systemic conditions like myasthenia gravis or thyroid eye disease.
Management depends on the cause. First-line treatment for accommodative esotropia is full correction of hyperopia with glasses or contact lenses, which often restores alignment. In cases with high AC/A ratio, bifocals may be required. Treatment of amblyopia with patching or atropine drops is critical.
Medications are generally not used, except in specific conditions such as myasthenia gravis. Vision therapy has no proven role in treatment.
Surgical intervention is indicated when alignment cannot be adequately controlled with optical correction. Procedures typically involve recession or resection of extraocular muscles, most commonly bilateral medial rectus recession. Surgery is usually performed on an outpatient basis.
Follow-up is essential, especially in children. Stable accommodative esotropia is typically monitored every 3–4 months, while more variable cases require closer observation. Parents should monitor eye alignment, and patients should report frequency of diplopia if present.
The prognosis varies by subtype. In accommodative esotropia, approximately one-third require lifelong glasses, one-third outgrow the need, and one-third eventually need surgery. Outcomes depend on early detection and treatment, particularly for preventing amblyopia. Acute cases depend on the underlying cause.
Complications include amblyopia and potential over- or undercorrection after surgery. Rare surgical risks include infection, hemorrhage, or muscle complications, though overall outcomes are generally favorable with appropriate management.
Comitant esotropia is a form of strabismus in which one eye deviates inward toward the nose, with the key feature that the angle of deviation remains the same in all directions of gaze. It may be intermittent or constant and includes several subtypes such as accommodative, nonaccommodative, sensory, congenital/infantile, consecutive (after exotropia surgery), and cyclic esotropia. Rarely, it may be associated with systemic conditions such as ocular myasthenia gravis or thyroid eye disease.
This condition is relatively common in childhood, with an incidence of about 111 per 100,000 children under 19 years and a prevalence of approximately 2% in children under 6 years. Risk factors include hyperopia (farsightedness), poor vision in one or both eyes (sensory esotropia), prematurity, cerebral palsy, seizure disorders, and developmental delay. There is also a multifactorial genetic component, particularly in accommodative esotropia, where a strong family history is often present.
The pathophysiology depends on the subtype. In accommodative esotropia, excessive focusing effort to overcome hyperopia leads to increased convergence, resulting in inward deviation. In other forms, no clear abnormality in muscles or nerves is identified. Acute onset esotropia may raise concern for intracranial pathology such as tumors, Chiari malformation, or hydrocephalus.
Etiologically, accommodative esotropia is strongly linked to uncorrected hyperopia. Sensory esotropia arises when poor vision disrupts binocular alignment, often due to conditions like cataract or retinal disease. Acute comitant esotropia may indicate neurologic disease, and should prompt further evaluation.
Clinically, esotropia is often first noticed by parents in children, sometimes beginning intermittently and progressing to constant deviation. Symptoms may include crossed eyes, diplopia (in acute cases), or decreased vision. A history of neurologic issues, developmental delay, or prematurity may also be present.
On examination, a complete ophthalmic evaluation is essential. This includes cycloplegic refraction (often requiring atropine), assessment of ocular alignment in all gaze positions, and testing of stereoacuity. The AC/A ratio (accommodative convergence to accommodation) is particularly important in evaluating accommodative esotropia. Visual acuity testing is crucial to identify amblyopia, a common associated condition.
Diagnostic testing is usually not required unless atypical features are present. In suspected cases of myasthenia gravis, antibody testing or a Tensilon test may be performed. If thyroid eye disease is suspected, thyroid function tests are indicated. Neuroimaging (MRI of brain and orbits) is reserved for cases with acute onset or associated neurologic signs.
The differential diagnosis includes pseudoesotropia (common in infants with prominent epicanthal folds), incomitant esotropia, and systemic conditions like myasthenia gravis or thyroid eye disease.
Management depends on the cause. First-line treatment for accommodative esotropia is full correction of hyperopia with glasses or contact lenses, which often restores alignment. In cases with high AC/A ratio, bifocals may be required. Treatment of amblyopia with patching or atropine drops is critical.
Medications are generally not used, except in specific conditions such as myasthenia gravis. Vision therapy has no proven role in treatment.
Surgical intervention is indicated when alignment cannot be adequately controlled with optical correction. Procedures typically involve recession or resection of extraocular muscles, most commonly bilateral medial rectus recession. Surgery is usually performed on an outpatient basis.
Follow-up is essential, especially in children. Stable accommodative esotropia is typically monitored every 3–4 months, while more variable cases require closer observation. Parents should monitor eye alignment, and patients should report frequency of diplopia if present.
The prognosis varies by subtype. In accommodative esotropia, approximately one-third require lifelong glasses, one-third outgrow the need, and one-third eventually need surgery. Outcomes depend on early detection and treatment, particularly for preventing amblyopia. Acute cases depend on the underlying cause.
Complications include amblyopia and potential over- or undercorrection after surgery. Rare surgical risks include infection, hemorrhage, or muscle complications, though overall outcomes are generally favorable with appropriate management.
- Published on
Ophthalmology – Duane Syndrome
Duane syndrome is a congenital eye movement disorder characterized primarily by limited abduction (outward movement of the eye), along with globe retraction and narrowing of the palpebral fissure on attempted adduction. It is classified into three types: Type I, the most common, shows marked limitation of abduction with relatively preserved adduction; Type II shows limitation of adduction with exotropia; and Type III involves limitation of both abduction and adduction. The condition is part of a group known as congenital cranial dysinnervation disorders, reflecting abnormal nerve supply to the extraocular muscles.
Duane syndrome accounts for about 1% of all strabismus cases and is more common in females, with unilateral involvement being more typical than bilateral. Risk factors include thalidomide exposure during early pregnancy and associations with certain congenital syndromes. Genetically, mutations in genes such as CHN1 and CPAH have been identified, usually with an autosomal dominant inheritance pattern, though many cases are sporadic.
The underlying pathophysiology involves absence or hypoplasia of the sixth cranial nerve (abducens nerve) and abnormal innervation of the lateral rectus muscle by the oculomotor nerve. This leads to co-contraction of medial and lateral rectus muscles, causing globe retraction and narrowing of the eyelid fissure during adduction. The characteristic upshoots and downshoots seen in some patients are thought to result from a mechanical “leash effect” or anomalous muscle innervation.
Clinically, children often present with an eye that does not move outward properly, sometimes associated with esotropia and a compensatory head turn (face turn) to maintain binocular vision. On examination, key findings include limited abduction, variable limitation of adduction, globe retraction on adduction, and vertical upshoots or downshoots. A full ocular exam is essential, particularly to assess for amblyopia, refractive error, and abnormal head posture. Some patients may also have associated ocular findings such as iris abnormalities, cataracts, or coloboma, as well as systemic associations like hearing loss.
Diagnosis is primarily clinical, though high-resolution MRI may demonstrate absence or abnormality of the sixth nerve. Audiologic evaluation is recommended in cases with suspected associated syndromes. The differential diagnosis includes sixth nerve palsy, congenital esotropia, and orbital restrictive conditions.
Management focuses on optimizing vision and alignment. Refractive errors and amblyopia must be treated first with glasses or occlusion therapy. Surgical intervention is considered when there is a significant deviation in primary gaze, abnormal head posture, or cosmetically significant globe retraction or up/down shoots. Surgical approaches typically involve recession of the medial or lateral rectus muscles, and in selected cases, muscle transposition procedures. Importantly, resection of the lateral rectus is generally avoided as it can worsen globe retraction.
The prognosis for vision is excellent if amblyopia is addressed early. While surgery can improve alignment and reduce abnormal head posture, it does not fully restore normal eye movements, particularly abduction. Long-term follow-up is important to monitor for amblyopia, recurrent strabismus, and head posture abnormalities.
Duane syndrome is a congenital eye movement disorder characterized primarily by limited abduction (outward movement of the eye), along with globe retraction and narrowing of the palpebral fissure on attempted adduction. It is classified into three types: Type I, the most common, shows marked limitation of abduction with relatively preserved adduction; Type II shows limitation of adduction with exotropia; and Type III involves limitation of both abduction and adduction. The condition is part of a group known as congenital cranial dysinnervation disorders, reflecting abnormal nerve supply to the extraocular muscles.
Duane syndrome accounts for about 1% of all strabismus cases and is more common in females, with unilateral involvement being more typical than bilateral. Risk factors include thalidomide exposure during early pregnancy and associations with certain congenital syndromes. Genetically, mutations in genes such as CHN1 and CPAH have been identified, usually with an autosomal dominant inheritance pattern, though many cases are sporadic.
The underlying pathophysiology involves absence or hypoplasia of the sixth cranial nerve (abducens nerve) and abnormal innervation of the lateral rectus muscle by the oculomotor nerve. This leads to co-contraction of medial and lateral rectus muscles, causing globe retraction and narrowing of the eyelid fissure during adduction. The characteristic upshoots and downshoots seen in some patients are thought to result from a mechanical “leash effect” or anomalous muscle innervation.
Clinically, children often present with an eye that does not move outward properly, sometimes associated with esotropia and a compensatory head turn (face turn) to maintain binocular vision. On examination, key findings include limited abduction, variable limitation of adduction, globe retraction on adduction, and vertical upshoots or downshoots. A full ocular exam is essential, particularly to assess for amblyopia, refractive error, and abnormal head posture. Some patients may also have associated ocular findings such as iris abnormalities, cataracts, or coloboma, as well as systemic associations like hearing loss.
Diagnosis is primarily clinical, though high-resolution MRI may demonstrate absence or abnormality of the sixth nerve. Audiologic evaluation is recommended in cases with suspected associated syndromes. The differential diagnosis includes sixth nerve palsy, congenital esotropia, and orbital restrictive conditions.
Management focuses on optimizing vision and alignment. Refractive errors and amblyopia must be treated first with glasses or occlusion therapy. Surgical intervention is considered when there is a significant deviation in primary gaze, abnormal head posture, or cosmetically significant globe retraction or up/down shoots. Surgical approaches typically involve recession of the medial or lateral rectus muscles, and in selected cases, muscle transposition procedures. Importantly, resection of the lateral rectus is generally avoided as it can worsen globe retraction.
The prognosis for vision is excellent if amblyopia is addressed early. While surgery can improve alignment and reduce abnormal head posture, it does not fully restore normal eye movements, particularly abduction. Long-term follow-up is important to monitor for amblyopia, recurrent strabismus, and head posture abnormalities.
- Published on
Ophthalmology – Dyslexia
Dyslexia is a primary reading disorder characterized by difficulty in acquiring accurate and fluent reading skills due to a language-processing abnormality in the brain. It is not caused by poor vision, low intelligence, lack of motivation, or inadequate teaching. Instead, dyslexia primarily results from a deficit in phonological processing, meaning difficulty in recognizing and manipulating the sounds of language. Historically referred to as “word blindness,” it is now well established that dyslexia is not a visual disorder, although children may appear to skip words or reverse letters due to underlying language-processing challenges.
Dyslexia is relatively common, affecting approximately 5–17% of children, with boys diagnosed more frequently than girls. It exists along a continuum of reading ability in the population, with dyslexia representing the lower end. There is a strong genetic component, with heritability estimated between 54–75%. It often runs in families, and multiple genetic loci have been identified, supporting a polygenic inheritance pattern.
The underlying pathophysiology involves abnormal activation of left hemisphere brain regions responsible for reading, particularly the temporoparietal and occipitotemporal areas. Individuals with dyslexia show reduced activity in these regions and may compensate by using alternative neural pathways, such as frontal brain regions. These differences highlight that dyslexia is a neurobiological disorder of language processing, not an ocular or visual tracking problem.
Clinically, younger children may present with language delay, difficulty learning letters, trouble with rhymes, or mispronouncing words. Older children often demonstrate slow, effortful reading, poor spelling, and a mismatch between their reading ability and overall intelligence. Importantly, children with dyslexia generally have normal eye health and visual function, and any abnormal eye movements observed are a consequence—not a cause—of reading difficulty.
Evaluation of suspected dyslexia includes hearing and vision screening to rule out contributing factors, followed by formal educational and neuropsychological testing. Diagnosis is made using standardized assessments of reading, phonological processing, and comprehension by trained specialists such as psychologists or educators. Imaging studies are not routinely required.
Management is centered on early, structured educational intervention, particularly focusing on phonological awareness and decoding skills. Early intervention (especially between ages 6–8) significantly improves outcomes. Older children benefit from academic accommodations, such as extra time, audiobooks, and assistive technology. It is important to note that vision therapy, eye exercises, and colored lenses have not been proven effective for treating dyslexia.
The prognosis is variable but generally reflects a chronic condition rather than a temporary delay. Without early intervention, reading difficulties often persist into adolescence and adulthood. However, with appropriate support and tailored instruction, many individuals with dyslexia can achieve strong academic and functional outcomes.
Dyslexia is a primary reading disorder characterized by difficulty in acquiring accurate and fluent reading skills due to a language-processing abnormality in the brain. It is not caused by poor vision, low intelligence, lack of motivation, or inadequate teaching. Instead, dyslexia primarily results from a deficit in phonological processing, meaning difficulty in recognizing and manipulating the sounds of language. Historically referred to as “word blindness,” it is now well established that dyslexia is not a visual disorder, although children may appear to skip words or reverse letters due to underlying language-processing challenges.
Dyslexia is relatively common, affecting approximately 5–17% of children, with boys diagnosed more frequently than girls. It exists along a continuum of reading ability in the population, with dyslexia representing the lower end. There is a strong genetic component, with heritability estimated between 54–75%. It often runs in families, and multiple genetic loci have been identified, supporting a polygenic inheritance pattern.
The underlying pathophysiology involves abnormal activation of left hemisphere brain regions responsible for reading, particularly the temporoparietal and occipitotemporal areas. Individuals with dyslexia show reduced activity in these regions and may compensate by using alternative neural pathways, such as frontal brain regions. These differences highlight that dyslexia is a neurobiological disorder of language processing, not an ocular or visual tracking problem.
Clinically, younger children may present with language delay, difficulty learning letters, trouble with rhymes, or mispronouncing words. Older children often demonstrate slow, effortful reading, poor spelling, and a mismatch between their reading ability and overall intelligence. Importantly, children with dyslexia generally have normal eye health and visual function, and any abnormal eye movements observed are a consequence—not a cause—of reading difficulty.
Evaluation of suspected dyslexia includes hearing and vision screening to rule out contributing factors, followed by formal educational and neuropsychological testing. Diagnosis is made using standardized assessments of reading, phonological processing, and comprehension by trained specialists such as psychologists or educators. Imaging studies are not routinely required.
Management is centered on early, structured educational intervention, particularly focusing on phonological awareness and decoding skills. Early intervention (especially between ages 6–8) significantly improves outcomes. Older children benefit from academic accommodations, such as extra time, audiobooks, and assistive technology. It is important to note that vision therapy, eye exercises, and colored lenses have not been proven effective for treating dyslexia.
The prognosis is variable but generally reflects a chronic condition rather than a temporary delay. Without early intervention, reading difficulties often persist into adolescence and adulthood. However, with appropriate support and tailored instruction, many individuals with dyslexia can achieve strong academic and functional outcomes.
- Published on
Ophthalmology – Eales Disease
Eales disease is an idiopathic obliterative retinal vasculopathy that primarily affects young adults, classically presenting with a triad of retinal phlebitis, peripheral retinal nonperfusion, and recurrent vitreous hemorrhage. It is considered a diagnosis of exclusion, meaning other causes of retinal vasculitis must be ruled out before confirming the condition.
The disease is most commonly reported in regions such as India and the Middle East, typically affecting individuals between 20 and 30 years of age. Earlier studies suggested a male predominance, but more recent data indicate a more equal gender distribution. A possible association with hypersensitivity to tuberculin protein has been proposed, and tubercle bacilli have occasionally been identified in pathological specimens, although the exact cause remains unclear.
Pathophysiologically, Eales disease involves a nonspecific inflammatory occlusive vasculitis, primarily affecting retinal veins. This leads to vascular inflammation (phlebitis), followed by capillary closure and ischemia, which in turn stimulates retinal neovascularization. These fragile new vessels are prone to bleeding, resulting in recurrent vitreous hemorrhage, a hallmark complication.
Patients commonly present with decreased vision, floaters, or “cobweb-like” visual disturbances, often due to vitreous hemorrhage. On examination, findings include retinal vascular sheathing, hemorrhages, and exudates along affected vessels. More than half of patients have bilateral involvement. Additional findings may include vitreous cells, cystoid macular edema, and neovascularization of the retina or optic disc, which can progress to neovascular glaucoma if untreated.
Diagnosis relies heavily on fluorescein angiography, which helps identify areas of retinal nonperfusion, vascular leakage, and neovascularization. Optical coherence tomography (OCT) may detect associated macular edema or epiretinal membranes. Since Eales disease is a diagnosis of exclusion, investigations are necessary to rule out other causes such as diabetes, sickle cell disease, retinal vein occlusion, inflammatory or infectious vasculitis, and systemic autoimmune conditions.
Management focuses on controlling complications. Panretinal photocoagulation (laser therapy) is essential in cases with retinal ischemia and neovascularization to prevent further hemorrhage and tractional complications. Corticosteroids, either systemic or intravitreal, may help reduce inflammation and vascular leakage. Anti-VEGF agents (such as bevacizumab) are sometimes used to induce regression of neovascularization. In advanced cases with persistent vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be required.
Patients require regular follow-up every 3 to 12 months, depending on disease severity, to monitor for progression and complications. Education is important—patients should be aware of symptoms such as sudden floaters or vision loss, which may indicate vitreous hemorrhage.
The prognosis is generally favorable with appropriate management, with many patients maintaining visual acuity of 20/40 or better. However, complications such as recurrent vitreous hemorrhage, retinal detachment, and neovascular glaucoma can significantly impact vision if not treated promptly.
Eales disease is an idiopathic obliterative retinal vasculopathy that primarily affects young adults, classically presenting with a triad of retinal phlebitis, peripheral retinal nonperfusion, and recurrent vitreous hemorrhage. It is considered a diagnosis of exclusion, meaning other causes of retinal vasculitis must be ruled out before confirming the condition.
The disease is most commonly reported in regions such as India and the Middle East, typically affecting individuals between 20 and 30 years of age. Earlier studies suggested a male predominance, but more recent data indicate a more equal gender distribution. A possible association with hypersensitivity to tuberculin protein has been proposed, and tubercle bacilli have occasionally been identified in pathological specimens, although the exact cause remains unclear.
Pathophysiologically, Eales disease involves a nonspecific inflammatory occlusive vasculitis, primarily affecting retinal veins. This leads to vascular inflammation (phlebitis), followed by capillary closure and ischemia, which in turn stimulates retinal neovascularization. These fragile new vessels are prone to bleeding, resulting in recurrent vitreous hemorrhage, a hallmark complication.
Patients commonly present with decreased vision, floaters, or “cobweb-like” visual disturbances, often due to vitreous hemorrhage. On examination, findings include retinal vascular sheathing, hemorrhages, and exudates along affected vessels. More than half of patients have bilateral involvement. Additional findings may include vitreous cells, cystoid macular edema, and neovascularization of the retina or optic disc, which can progress to neovascular glaucoma if untreated.
Diagnosis relies heavily on fluorescein angiography, which helps identify areas of retinal nonperfusion, vascular leakage, and neovascularization. Optical coherence tomography (OCT) may detect associated macular edema or epiretinal membranes. Since Eales disease is a diagnosis of exclusion, investigations are necessary to rule out other causes such as diabetes, sickle cell disease, retinal vein occlusion, inflammatory or infectious vasculitis, and systemic autoimmune conditions.
Management focuses on controlling complications. Panretinal photocoagulation (laser therapy) is essential in cases with retinal ischemia and neovascularization to prevent further hemorrhage and tractional complications. Corticosteroids, either systemic or intravitreal, may help reduce inflammation and vascular leakage. Anti-VEGF agents (such as bevacizumab) are sometimes used to induce regression of neovascularization. In advanced cases with persistent vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be required.
Patients require regular follow-up every 3 to 12 months, depending on disease severity, to monitor for progression and complications. Education is important—patients should be aware of symptoms such as sudden floaters or vision loss, which may indicate vitreous hemorrhage.
The prognosis is generally favorable with appropriate management, with many patients maintaining visual acuity of 20/40 or better. However, complications such as recurrent vitreous hemorrhage, retinal detachment, and neovascular glaucoma can significantly impact vision if not treated promptly.
- Published on
Ophthalmology – Ectopia Lentis
Ectopia lentis refers to displacement of the crystalline lens from its normal position due to weakness or disruption of the zonular fibers. The condition may present as subluxation (partial displacement) or luxation (complete dislocation). It can occur as an isolated ocular finding or as part of systemic connective tissue or metabolic disorders, and may also result from trauma.
The condition is strongly associated with systemic diseases such as Marfan syndrome (where 60–75% of patients develop ectopia lentis) and homocystinuria (seen in 80–85% of cases). Other associations include Ehlers–Danlos syndrome, Weill–Marchesani syndrome, hyperlysinemia, sulfite oxidase deficiency, and congenital ocular anomalies. Trauma is also an important cause, particularly in unilateral cases. Genetically, ectopia lentis may be inherited in autosomal dominant or recessive patterns, often involving mutations in genes such as FBN1 (fibrillin) or ADAMTSL4, both critical for zonular integrity.
The underlying pathophysiology involves weakening, stretching, or rupture of the zonular fibers that suspend the lens. In connective tissue disorders like Marfan syndrome, abnormal fibrillin leads to fragile zonules, whereas in metabolic disorders like homocystinuria, defective cysteine metabolism weakens zonular structure. This results in progressive lens instability and displacement.
Patients may present with blurred vision, monocular diplopia, or fluctuating refractive error, depending on the degree of lens displacement. A history of trauma or systemic disease, or a family history, may be present. On examination, slit-lamp findings reveal decentered lens position, abnormal zonules (stretched, broken, or absent), and sometimes irregular lens edges. Additional findings may include corectopia (displaced pupil), elevated intraocular pressure, or signs of associated systemic disease.
Diagnostic evaluation includes a thorough ocular exam and systemic assessment. In patients without trauma or known diagnosis, serum or urine homocysteine levels should be checked due to the serious systemic risks of homocystinuria, including thromboembolism. Imaging such as echocardiography may be required when conditions like Marfan syndrome are suspected. Genetic testing may help confirm the diagnosis in selected cases.
Management depends on severity and underlying cause. Initial treatment focuses on optical correction with glasses or contact lenses and treatment of amblyopia, especially in children. In cases where the lens dislocates into the anterior chamber, urgent management is required to prevent pupillary block glaucoma, including medications such as mannitol, steroids, and mydriatics, along with positioning the patient supine.
Surgical treatment is indicated when vision cannot be corrected optically or when complications arise. This typically involves lensectomy with anterior vitrectomy, followed by visual rehabilitation using contact lenses or aphakic spectacles. In some cases, intraocular lens implantation may be considered, though this is often limited in children due to poor zonular support.
Regular follow-up is essential to monitor for progressive lens displacement, amblyopia, glaucoma, and retinal detachment, particularly in conditions like Marfan syndrome. Prognosis is generally good with early diagnosis and appropriate management, with many patients achieving visual acuity of 20/40 or better, provided complications are addressed promptly.
Ectopia lentis refers to displacement of the crystalline lens from its normal position due to weakness or disruption of the zonular fibers. The condition may present as subluxation (partial displacement) or luxation (complete dislocation). It can occur as an isolated ocular finding or as part of systemic connective tissue or metabolic disorders, and may also result from trauma.
The condition is strongly associated with systemic diseases such as Marfan syndrome (where 60–75% of patients develop ectopia lentis) and homocystinuria (seen in 80–85% of cases). Other associations include Ehlers–Danlos syndrome, Weill–Marchesani syndrome, hyperlysinemia, sulfite oxidase deficiency, and congenital ocular anomalies. Trauma is also an important cause, particularly in unilateral cases. Genetically, ectopia lentis may be inherited in autosomal dominant or recessive patterns, often involving mutations in genes such as FBN1 (fibrillin) or ADAMTSL4, both critical for zonular integrity.
The underlying pathophysiology involves weakening, stretching, or rupture of the zonular fibers that suspend the lens. In connective tissue disorders like Marfan syndrome, abnormal fibrillin leads to fragile zonules, whereas in metabolic disorders like homocystinuria, defective cysteine metabolism weakens zonular structure. This results in progressive lens instability and displacement.
Patients may present with blurred vision, monocular diplopia, or fluctuating refractive error, depending on the degree of lens displacement. A history of trauma or systemic disease, or a family history, may be present. On examination, slit-lamp findings reveal decentered lens position, abnormal zonules (stretched, broken, or absent), and sometimes irregular lens edges. Additional findings may include corectopia (displaced pupil), elevated intraocular pressure, or signs of associated systemic disease.
Diagnostic evaluation includes a thorough ocular exam and systemic assessment. In patients without trauma or known diagnosis, serum or urine homocysteine levels should be checked due to the serious systemic risks of homocystinuria, including thromboembolism. Imaging such as echocardiography may be required when conditions like Marfan syndrome are suspected. Genetic testing may help confirm the diagnosis in selected cases.
Management depends on severity and underlying cause. Initial treatment focuses on optical correction with glasses or contact lenses and treatment of amblyopia, especially in children. In cases where the lens dislocates into the anterior chamber, urgent management is required to prevent pupillary block glaucoma, including medications such as mannitol, steroids, and mydriatics, along with positioning the patient supine.
Surgical treatment is indicated when vision cannot be corrected optically or when complications arise. This typically involves lensectomy with anterior vitrectomy, followed by visual rehabilitation using contact lenses or aphakic spectacles. In some cases, intraocular lens implantation may be considered, though this is often limited in children due to poor zonular support.
Regular follow-up is essential to monitor for progressive lens displacement, amblyopia, glaucoma, and retinal detachment, particularly in conditions like Marfan syndrome. Prognosis is generally good with early diagnosis and appropriate management, with many patients achieving visual acuity of 20/40 or better, provided complications are addressed promptly.
- Published on
Ophthalmology – Ectropion
Ectropion is defined as an outward turning (eversion) of the eyelid margin, most commonly affecting the lower eyelid. This malposition disrupts normal eyelid function, leading to exposure of the ocular surface and improper tear drainage. Ectropion is classified into several types, including involutional (age-related, most common), paralytic, cicatricial, and congenital forms.
The condition is most frequently seen in older adults, particularly due to age-related tissue changes. Risk factors include sun exposure, smoking, diabetes, hypertension, and prior facial or eyelid surgery. Paralytic ectropion is often associated with facial nerve (7th nerve) palsy, such as in Bell’s palsy, while cicatricial ectropion results from skin contracture due to scarring, trauma, inflammation, or tumors.
Pathophysiologically, involutional ectropion results from horizontal eyelid laxity and weakening of supporting structures. Paralytic ectropion occurs due to loss of orbicularis oculi muscle tone, leading to poor eyelid closure and sagging. Cicatricial ectropion is caused by shortening or tightening of the anterior lamella (skin), pulling the eyelid outward. These mechanisms ultimately result in poor eyelid-globe apposition and exposure of the conjunctiva and cornea.
Patients typically present with tearing (epiphora), redness, foreign body sensation, mucous discharge, and irritation. Symptoms occur because the lacrimal punctum is everted, preventing proper tear drainage, and because of ocular surface exposure. On examination, findings include visible outward turning of the eyelid, punctal eversion, lagophthalmos (incomplete eyelid closure), conjunctival redness, and superficial punctate keratitis. In paralytic cases, signs of facial nerve dysfunction such as reduced eyelid closure strength are evident.
Diagnosis is primarily clinical, though additional testing may be required depending on the cause. For example, Lyme titers may be checked in suspected infectious facial palsy, and evaluation for herpes zoster or systemic disease may be indicated. The differential diagnosis includes conditions such as thyroid eye disease and floppy eyelid syndrome.
Management depends on severity and underlying cause. Initial treatment focuses on ocular surface protection, including artificial tears, gels, and ointments to prevent dryness and corneal damage. In cases of infection or inflammation, topical antibiotic or steroid ointments may be used. For paralytic ectropion, treatment may include systemic corticosteroids, antivirals, or antibiotics, depending on etiology.
Supportive measures include warm compresses, eyelid taping, and massage, particularly in mild or temporary cases. However, definitive treatment is often surgical. Involutional ectropion is typically corrected with horizontal eyelid tightening procedures, while paralytic ectropion may require procedures such as gold weight implantation in the upper eyelid to improve closure. Cicatricial ectropion often requires skin grafting or reconstructive procedures to address tissue deficiency.
Follow-up is important to monitor for complications, particularly corneal exposure. Prognosis is generally good, especially when treated early. However, untreated ectropion can lead to serious complications such as corneal abrasion, ulceration, scarring, and even perforation, making timely management essential.
Ectropion is defined as an outward turning (eversion) of the eyelid margin, most commonly affecting the lower eyelid. This malposition disrupts normal eyelid function, leading to exposure of the ocular surface and improper tear drainage. Ectropion is classified into several types, including involutional (age-related, most common), paralytic, cicatricial, and congenital forms.
The condition is most frequently seen in older adults, particularly due to age-related tissue changes. Risk factors include sun exposure, smoking, diabetes, hypertension, and prior facial or eyelid surgery. Paralytic ectropion is often associated with facial nerve (7th nerve) palsy, such as in Bell’s palsy, while cicatricial ectropion results from skin contracture due to scarring, trauma, inflammation, or tumors.
Pathophysiologically, involutional ectropion results from horizontal eyelid laxity and weakening of supporting structures. Paralytic ectropion occurs due to loss of orbicularis oculi muscle tone, leading to poor eyelid closure and sagging. Cicatricial ectropion is caused by shortening or tightening of the anterior lamella (skin), pulling the eyelid outward. These mechanisms ultimately result in poor eyelid-globe apposition and exposure of the conjunctiva and cornea.
Patients typically present with tearing (epiphora), redness, foreign body sensation, mucous discharge, and irritation. Symptoms occur because the lacrimal punctum is everted, preventing proper tear drainage, and because of ocular surface exposure. On examination, findings include visible outward turning of the eyelid, punctal eversion, lagophthalmos (incomplete eyelid closure), conjunctival redness, and superficial punctate keratitis. In paralytic cases, signs of facial nerve dysfunction such as reduced eyelid closure strength are evident.
Diagnosis is primarily clinical, though additional testing may be required depending on the cause. For example, Lyme titers may be checked in suspected infectious facial palsy, and evaluation for herpes zoster or systemic disease may be indicated. The differential diagnosis includes conditions such as thyroid eye disease and floppy eyelid syndrome.
Management depends on severity and underlying cause. Initial treatment focuses on ocular surface protection, including artificial tears, gels, and ointments to prevent dryness and corneal damage. In cases of infection or inflammation, topical antibiotic or steroid ointments may be used. For paralytic ectropion, treatment may include systemic corticosteroids, antivirals, or antibiotics, depending on etiology.
Supportive measures include warm compresses, eyelid taping, and massage, particularly in mild or temporary cases. However, definitive treatment is often surgical. Involutional ectropion is typically corrected with horizontal eyelid tightening procedures, while paralytic ectropion may require procedures such as gold weight implantation in the upper eyelid to improve closure. Cicatricial ectropion often requires skin grafting or reconstructive procedures to address tissue deficiency.
Follow-up is important to monitor for complications, particularly corneal exposure. Prognosis is generally good, especially when treated early. However, untreated ectropion can lead to serious complications such as corneal abrasion, ulceration, scarring, and even perforation, making timely management essential.
- Published on
Ophthalmology – Epiretinal Membranes (ERM)
Epiretinal membranes (ERM), also known as macular pucker, cellophane maculopathy, or surface wrinkling retinopathy, are thin fibrocellular layers that form on the inner surface of the retina, particularly over the macula. While many cases are mild and asymptomatic, ERMs can distort the retinal architecture, leading to blurred vision and metamorphopsia (distorted vision). They are commonly associated with posterior vitreous detachment (PVD) and may coexist with vitreomacular traction.
ERM is primarily a disease of the elderly population, with prevalence increasing significantly with age. It is found in about 2% of individuals at age 50, rising to 20% by age 75. Although bilateral in 20–30% of cases, it is often asymmetric. Risk factors include female gender, aging, prior ocular surgery or trauma, diabetes, retinal vascular disease, intraocular inflammation, and vitreous hemorrhage. Pediatric cases are rare and usually secondary to other ocular abnormalities.
The pathophysiology involves abnormal proliferation of glial cells (including Müller cells, astrocytes, fibrocytes, and myofibroblasts) on the retinal surface. These cells often migrate after a posterior vitreous detachment, although they may appear earlier. Over time, these cells can acquire contractile properties, exerting traction on the retina and leading to wrinkling, distortion, and reduced visual acuity.
ERM can be classified as idiopathic (primary) or secondary. Idiopathic ERMs occur without an identifiable cause, while secondary ERMs develop in association with retinal vascular diseases, inflammation, trauma, or prior surgery.
Clinically, many patients are asymptomatic, especially in early stages. Symptomatic patients may report gradual vision loss, distortion of straight lines (metamorphopsia), difficulty reading, or central blurring. Occasionally, patients may experience diplopia or photopsias.
On examination, subtle ERMs may appear as a shiny, glistening reflex on the macula, while more advanced cases show retinal folds (striae), vessel tortuosity, and macular thickening. In some cases, cystoid macular edema (CME) or small hemorrhages may be present due to traction.
Diagnosis is primarily clinical but is best confirmed with imaging. Optical coherence tomography (OCT) is the gold standard and demonstrates retinal surface wrinkling, thickening, and possible cystoid changes. OCT also helps assess prognosis, as disruption of photoreceptor layers or significant edema correlates with poorer outcomes. Fluorescein angiography (FA) may be used to evaluate for underlying vascular disease or macular leakage. Amsler grid testing is useful for monitoring visual distortion.
The differential diagnosis includes proliferative diabetic retinopathy, retinal vein occlusion-related fibrosis, and incomplete posterior vitreous detachment with adherent posterior hyaloid.
Management depends on symptom severity. Asymptomatic patients require no treatment and can be observed with periodic follow-up. For patients with mild edema, topical NSAIDs or steroids may be used. However, medical therapy is generally limited in effectiveness for ERM itself.
Definitive treatment is surgical, indicated in patients with significant visual symptoms or visual acuity worse than ~20/40. The procedure involves pars plana vitrectomy with membrane peeling, often including removal of the internal limiting membrane (ILM) to reduce recurrence risk. Advances in minimally invasive vitrectomy have improved recovery times and outcomes.
Follow-up includes routine monitoring and Amsler grid use, with prompt reassessment if symptoms worsen. Many ERMs remain stable for years, but progression can occur, especially after acute PVD or ocular surgery.
The prognosis is generally favorable. Asymptomatic patients maintain good vision, while 80–90% of surgical patients experience improvement of at least two Snellen lines. However, complete restoration to normal vision (20/20) is uncommon, and outcomes depend largely on preoperative visual acuity and retinal integrity.
Complications include cataract formation (most common), retinal tears or detachment, recurrent ERM, retinal phototoxicity, and rarely endophthalmitis.
Epiretinal membranes (ERM), also known as macular pucker, cellophane maculopathy, or surface wrinkling retinopathy, are thin fibrocellular layers that form on the inner surface of the retina, particularly over the macula. While many cases are mild and asymptomatic, ERMs can distort the retinal architecture, leading to blurred vision and metamorphopsia (distorted vision). They are commonly associated with posterior vitreous detachment (PVD) and may coexist with vitreomacular traction.
ERM is primarily a disease of the elderly population, with prevalence increasing significantly with age. It is found in about 2% of individuals at age 50, rising to 20% by age 75. Although bilateral in 20–30% of cases, it is often asymmetric. Risk factors include female gender, aging, prior ocular surgery or trauma, diabetes, retinal vascular disease, intraocular inflammation, and vitreous hemorrhage. Pediatric cases are rare and usually secondary to other ocular abnormalities.
The pathophysiology involves abnormal proliferation of glial cells (including Müller cells, astrocytes, fibrocytes, and myofibroblasts) on the retinal surface. These cells often migrate after a posterior vitreous detachment, although they may appear earlier. Over time, these cells can acquire contractile properties, exerting traction on the retina and leading to wrinkling, distortion, and reduced visual acuity.
ERM can be classified as idiopathic (primary) or secondary. Idiopathic ERMs occur without an identifiable cause, while secondary ERMs develop in association with retinal vascular diseases, inflammation, trauma, or prior surgery.
Clinically, many patients are asymptomatic, especially in early stages. Symptomatic patients may report gradual vision loss, distortion of straight lines (metamorphopsia), difficulty reading, or central blurring. Occasionally, patients may experience diplopia or photopsias.
On examination, subtle ERMs may appear as a shiny, glistening reflex on the macula, while more advanced cases show retinal folds (striae), vessel tortuosity, and macular thickening. In some cases, cystoid macular edema (CME) or small hemorrhages may be present due to traction.
Diagnosis is primarily clinical but is best confirmed with imaging. Optical coherence tomography (OCT) is the gold standard and demonstrates retinal surface wrinkling, thickening, and possible cystoid changes. OCT also helps assess prognosis, as disruption of photoreceptor layers or significant edema correlates with poorer outcomes. Fluorescein angiography (FA) may be used to evaluate for underlying vascular disease or macular leakage. Amsler grid testing is useful for monitoring visual distortion.
The differential diagnosis includes proliferative diabetic retinopathy, retinal vein occlusion-related fibrosis, and incomplete posterior vitreous detachment with adherent posterior hyaloid.
Management depends on symptom severity. Asymptomatic patients require no treatment and can be observed with periodic follow-up. For patients with mild edema, topical NSAIDs or steroids may be used. However, medical therapy is generally limited in effectiveness for ERM itself.
Definitive treatment is surgical, indicated in patients with significant visual symptoms or visual acuity worse than ~20/40. The procedure involves pars plana vitrectomy with membrane peeling, often including removal of the internal limiting membrane (ILM) to reduce recurrence risk. Advances in minimally invasive vitrectomy have improved recovery times and outcomes.
Follow-up includes routine monitoring and Amsler grid use, with prompt reassessment if symptoms worsen. Many ERMs remain stable for years, but progression can occur, especially after acute PVD or ocular surgery.
The prognosis is generally favorable. Asymptomatic patients maintain good vision, while 80–90% of surgical patients experience improvement of at least two Snellen lines. However, complete restoration to normal vision (20/20) is uncommon, and outcomes depend largely on preoperative visual acuity and retinal integrity.
Complications include cataract formation (most common), retinal tears or detachment, recurrent ERM, retinal phototoxicity, and rarely endophthalmitis.
- Published on
Ophthalmology – Epiphora
Epiphora, commonly referred to as excessive tearing, results from an imbalance between tear production and tear drainage. Tears are produced by the lacrimal glands and normally drain through the nasolacrimal system into the nose. Any disruption in this balance—either overproduction due to irritation or impaired drainage due to obstruction—can lead to tearing.
Epidemiologically, epiphora shows a bimodal distribution, occurring most often in infants and older adults. In infants, the most common cause is congenital nasolacrimal duct obstruction, affecting about 5% of newborns, with 90% resolving spontaneously by age 1. In adults, tearing is frequently due to dry eye syndrome, particularly in postmenopausal women, where ocular surface irritation leads to reflex tearing.
The pathophysiology involves disruption of the normal tear film dynamics. Tears consist of aqueous, lipid, and mucin layers that maintain ocular surface health. Blinking helps pump tears into the drainage system. In infants, incomplete canalization of the nasolacrimal duct leads to obstruction. In adults, dry eye or tear film instability causes irritation and reflex tearing. Other contributors include blepharitis (affecting lipid layer), decreased tear production, eyelid malposition (e.g., ectropion), or obstruction from inflammation, trauma, or infection.
Etiologically, epiphora can be broadly divided into overproduction and outflow obstruction. Overproduction is usually secondary to ocular surface irritation, such as from trichiasis, entropion, keratitis, uveitis, conjunctivitis, or foreign bodies. Outflow obstruction may occur anywhere along the lacrimal drainage pathway due to infection (dacryocystitis), inflammation, trauma, or medication-induced stenosis. Poor tear pump function from eyelid laxity or facial nerve palsy may also contribute.
Clinically, infants present with constant tearing shortly after birth, often accompanied by crusting of eyelashes, especially after sleep, and symptoms may worsen with nasal congestion. Adults with dry eye typically report intermittent tearing, worsened by activities that reduce blinking (e.g., reading, screen use, driving) or environmental factors like wind and cold air. In contrast, patients with obstruction often have constant tearing and may have a history of infection or trauma.
Physical examination includes assessment of the tear film quality and quantity, eyelid position (looking for entropion, ectropion, or misdirected lashes), and ocular surface for signs of dry eye or inflammation. Evaluation of the lacrimal drainage system includes inspection of the puncta, canaliculi, and lacrimal sac, with palpation to check for reflux of discharge suggestive of obstruction or infection.
Diagnostic testing may include the fluorescein dye disappearance test, where persistence of dye suggests impaired drainage. Schirmer testing evaluates tear production, with less than 5 mm of wetting in 5 minutes indicating dry eye. Additional studies such as dacryocystography or lacrimal scintigraphy can help differentiate obstruction from pump failure. Imaging (CT scan) may be used if structural abnormalities, cysts, or tumors are suspected. Lacrimal irrigation in-office is a useful diagnostic tool in older children and adults.
The differential diagnosis varies by age. In children, causes include congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon. In adults, common causes include dry eye, nasolacrimal duct obstruction, eyelid malposition, trichiasis, and facial nerve palsy, while acute causes include conjunctivitis, keratitis, uveitis, or foreign body.
Management depends on the underlying cause. In infants, conservative treatment includes topical antibiotic ointment for discharge and lacrimal sac massage, which can help open the duct. Most cases resolve spontaneously. In adults with dry eye, artificial tears are first-line, with second-line options including topical cyclosporine or short-term steroids for inflammation. Acute causes require treatment of the underlying condition, such as antibiotics for infection or removal of a foreign body.
Procedural interventions include punctal occlusion for dry eye, punctoplasty for stenosis, and probing and irrigation for congenital obstruction. Surgical options such as dacryocystorhinostomy (DCR) are used for persistent nasolacrimal duct obstruction. Eyelid malpositions may require entropion or ectropion repair.
Follow-up varies by age and severity. Infants are typically observed during the first year, with surgery considered if symptoms persist beyond age 1. Adults are managed based on cause, with surgical follow-up as needed. Prognosis is excellent in pediatric cases, while in adults it depends on the underlying etiology—patients with obstruction often do well after surgery, whereas those with chronic dry eye may have ongoing intermittent symptoms.
Epiphora, commonly referred to as excessive tearing, results from an imbalance between tear production and tear drainage. Tears are produced by the lacrimal glands and normally drain through the nasolacrimal system into the nose. Any disruption in this balance—either overproduction due to irritation or impaired drainage due to obstruction—can lead to tearing.
Epidemiologically, epiphora shows a bimodal distribution, occurring most often in infants and older adults. In infants, the most common cause is congenital nasolacrimal duct obstruction, affecting about 5% of newborns, with 90% resolving spontaneously by age 1. In adults, tearing is frequently due to dry eye syndrome, particularly in postmenopausal women, where ocular surface irritation leads to reflex tearing.
The pathophysiology involves disruption of the normal tear film dynamics. Tears consist of aqueous, lipid, and mucin layers that maintain ocular surface health. Blinking helps pump tears into the drainage system. In infants, incomplete canalization of the nasolacrimal duct leads to obstruction. In adults, dry eye or tear film instability causes irritation and reflex tearing. Other contributors include blepharitis (affecting lipid layer), decreased tear production, eyelid malposition (e.g., ectropion), or obstruction from inflammation, trauma, or infection.
Etiologically, epiphora can be broadly divided into overproduction and outflow obstruction. Overproduction is usually secondary to ocular surface irritation, such as from trichiasis, entropion, keratitis, uveitis, conjunctivitis, or foreign bodies. Outflow obstruction may occur anywhere along the lacrimal drainage pathway due to infection (dacryocystitis), inflammation, trauma, or medication-induced stenosis. Poor tear pump function from eyelid laxity or facial nerve palsy may also contribute.
Clinically, infants present with constant tearing shortly after birth, often accompanied by crusting of eyelashes, especially after sleep, and symptoms may worsen with nasal congestion. Adults with dry eye typically report intermittent tearing, worsened by activities that reduce blinking (e.g., reading, screen use, driving) or environmental factors like wind and cold air. In contrast, patients with obstruction often have constant tearing and may have a history of infection or trauma.
Physical examination includes assessment of the tear film quality and quantity, eyelid position (looking for entropion, ectropion, or misdirected lashes), and ocular surface for signs of dry eye or inflammation. Evaluation of the lacrimal drainage system includes inspection of the puncta, canaliculi, and lacrimal sac, with palpation to check for reflux of discharge suggestive of obstruction or infection.
Diagnostic testing may include the fluorescein dye disappearance test, where persistence of dye suggests impaired drainage. Schirmer testing evaluates tear production, with less than 5 mm of wetting in 5 minutes indicating dry eye. Additional studies such as dacryocystography or lacrimal scintigraphy can help differentiate obstruction from pump failure. Imaging (CT scan) may be used if structural abnormalities, cysts, or tumors are suspected. Lacrimal irrigation in-office is a useful diagnostic tool in older children and adults.
The differential diagnosis varies by age. In children, causes include congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon. In adults, common causes include dry eye, nasolacrimal duct obstruction, eyelid malposition, trichiasis, and facial nerve palsy, while acute causes include conjunctivitis, keratitis, uveitis, or foreign body.
Management depends on the underlying cause. In infants, conservative treatment includes topical antibiotic ointment for discharge and lacrimal sac massage, which can help open the duct. Most cases resolve spontaneously. In adults with dry eye, artificial tears are first-line, with second-line options including topical cyclosporine or short-term steroids for inflammation. Acute causes require treatment of the underlying condition, such as antibiotics for infection or removal of a foreign body.
Procedural interventions include punctal occlusion for dry eye, punctoplasty for stenosis, and probing and irrigation for congenital obstruction. Surgical options such as dacryocystorhinostomy (DCR) are used for persistent nasolacrimal duct obstruction. Eyelid malpositions may require entropion or ectropion repair.
Follow-up varies by age and severity. Infants are typically observed during the first year, with surgery considered if symptoms persist beyond age 1. Adults are managed based on cause, with surgical follow-up as needed. Prognosis is excellent in pediatric cases, while in adults it depends on the underlying etiology—patients with obstruction often do well after surgery, whereas those with chronic dry eye may have ongoing intermittent symptoms.
